Company intelligence / Profile preview

Cell-Therapy Technology Institute Inc.

Ownership: Private
Development stage: Commercial

Overview

The company's main clinical-stage asset was CyTIX‑01, an immunostimulant drug candidate. Its global highest R&D status is listed as "Discontinued." The company primarily focused on developing high-performance serum-free culture media to support research and manufacturing in regenerative medicine, stem cell therapy, cancer treatment, antibody/vaccine/recombinant protein production. There are no reported ongoing clinical trials or active programs.

Therapeutic areas: OtherOncology
Modalities: Immunostimulants (from CyTIX-01)Serum-free cell culture media for cell therapy and regenerative medicineMedia for iPS cells and MSCsMedia for antibody/vaccine/recombinant protein production
Industry: Chemicals & Materials

Drug pipeline

1 asset

DC/TC fusion vaccine + rhIL-12

Commercial

Indications: Cancer

Partnerships

Numerous joint R&D/public joint research projects with outside institutions are mentioned but none named specifically.

Beyond the preview

Go deeper on Cell-Therapy Technology Institute Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-Therapy Technology Institute Inc..

Explore the full profile